Lifestyle and genetic risk of chronic liver disease in metabolically healthy and unhealthy individuals from the general population

Background & Aims: It is unclear to what extent lifestyle and genetic factors affect the incidence of chronic liver disease (CLD) in the general population and if lifestyle affects CLD independently of underlying cardiometabolic perturbations and genetic predisposition. Methods: We examined...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	JHEP Reports
المؤلفون الرئيسيون:	Isabel Drake, Alice Giontella, Mariam Miari, Kristina Önnerhag, Marju Orho-Melander
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2024-08-01
الموضوعات:	chronic liver disease metabolic dysfunction-associated steatotic liver disease cirrhosis lifestyle diet polygenic risk
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2589555924001095

مواد مشابهة

Effect of smartphone-assisted lifestyle intervention in MASLD patients: a randomized controlled trial
حسب: Apichat Kaewdech, وآخرون
منشور في: (2024-06-01)

EAT-Lancet diet and risk of metabolic dysfunction-associated steatotic liver disease and other liver chronic diseases: a large prospective cohort study in the UK Biobank
حسب: Shi-Yi Wu, وآخرون
منشور في: (2025-07-01)

Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer risk
حسب: Núria Granel, وآخرون
منشور في: (2025-02-01)

Cirrhosis epidemiology in Denmark 1998–2022, and 2030 forecast
حسب: Linda Skibsted Kornerup, وآخرون
منشور في: (2025-05-01)

Fatty Liver Education Promotes Physical Activity in Vulnerable Groups, Including Those With Unhealthy Alcohol Use
حسب: Shyam Patel, وآخرون
منشور في: (2024-01-01)

Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
حسب: Weixiong Zhu, وآخرون
منشور في: (2025-07-01)

ALT levels, alcohol use, and metabolic risk factors have prognostic relevance for liver-related outcomes in the general population
حسب: Ville Männistö, وآخرون
منشور في: (2024-10-01)

Distinct Markers of Discordant Treatment Response to Lifestyle Intervention in MASLD, Independent of Weight Loss
حسب: Ling Luo, وآخرون
منشور في: (2025-09-01)

Editorial: Nutritional approaches in chronic liver diseases
حسب: Santiago Rodríguez Villafuerte, وآخرون
منشور في: (2024-09-01)

Metabolic dysfunction associated steatotic liver disease is associated with an increased risk of multiple respiratory system diseases
حسب: Bofu Liu, وآخرون
منشور في: (2025-05-01)

Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma
حسب: Melchor Alpízar Salazar, وآخرون
منشور في: (2025-01-01)

Essential tools for assessing advanced fibrosis in metabolic dysfunction-associated steatotic liver disease: Editorial on “Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis”
حسب: Won Sohn
منشور في: (2025-01-01)

Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials
حسب: Vicente Artola Arita, وآخرون
منشور في: (2025-08-01)

Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
حسب: K. L. Raikhelson, وآخرون
منشور في: (2024-05-01)

The Impact of Metabolic Health and Obesity on Liver Transplant Candidates and Recipients
حسب: Alexander S. Vogel, وآخرون
منشور في: (2024-05-01)

Gut microbiota in liver diseases: initiation, development and therapy
حسب: Jian-Xiu Yu, وآخرون
منشور في: (2025-06-01)

Higher lifestyle oxidative balance scores are associated with lower metabolic dysfunction-associated fatty liver disease and fibrosis risk in US adults, while dietary scores have no impact on fibrosis
حسب: Yan Chu, وآخرون
منشور في: (2025-04-01)

Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis
حسب: Nicholas A. Rouillard, وآخرون
منشور في: (2025-01-01)

Mitochondrial Dysfunction-Associated Mechanisms in the Development of Chronic Liver Diseases
حسب: Madan Kumar Arumugam, وآخرون
منشور في: (2023-10-01)

Age-specific protective effects of statins against cirrhosis in patients with chronic liver enzyme elevation associated with metabolic dysfunction: a retrospective cohort study of electronic health recordsResearch in context
حسب: Ayako Suzuki, وآخرون
منشور في: (2025-09-01)

Effect of a Ketogenic Diet on Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) Progression: A Randomized Controlled Trial
حسب: Sakkarin Chirapongsathorn, وآخرون
منشور في: (2025-01-01)

Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
حسب: Amani Elshaer, وآخرون
منشور في: (2024-07-01)

A leap in the dark: Bariatric surgery for treatment of metabolic dysfunction-associated steatotic liver disease related cirrhosis: Editorial on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
حسب: Jing Zeng, وآخرون
منشور في: (2025-04-01)

Diverting hepatic lipid fluxes with lifestyles revision and pharmacological interventions as a strategy to tackle steatotic liver disease (SLD) and hepatocellular carcinoma (HCC)
حسب: Davide Misceo, وآخرون
منشور في: (2024-12-01)

Associations of Unhealthy Lifestyle and Nonalcoholic Fatty Liver Disease With Cardiovascular Healthy Outcomes
حسب: Wentao Wu, وآخرون
منشور في: (2023-12-01)

Effect of liver biopsy size on MASLD fibrosis assessment by second-harmonic generation/two-photon excitation fluorescence microscopy
حسب: Daniel T. Field, وآخرون
منشور في: (2025-08-01)

Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Subclassification
حسب: Byeong Geun Song, وآخرون
منشور في: (2024-03-01)

Impact of steatotic liver disease subtypes, sarcopenia, and fibrosis on all-cause and cause-specific mortality: a 15.7-year cohort study
حسب: Yebei Liang, وآخرون
منشور في: (2025-02-01)

TM6SF2 and PNPLA3: A potential dynamic duo?: Editorial on “TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD”
حسب: Andrea Caddeo, وآخرون
منشور في: (2025-01-01)

Role of waist circumference, body mass index and high-sensitivity C-reactive protein in pediatric steatotic liver disease: A cross-sectional study
حسب: Qiaoling Wu, وآخرون
منشور في: (2025-01-01)

Reply to correspondence on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
حسب: Jing Zeng, وآخرون
منشور في: (2025-04-01)

The impact of fasting on cardiovascular risk control in patients with metabolic dysfunction-associated steatotic liver disease
حسب: Anna E. Płatek, وآخرون
منشور في: (2023-09-01)

Differential prevalence and prognostic value of metabolic syndrome components among patients with MASLD
حسب: Jesse Pustjens, وآخرون
منشور في: (2024-12-01)

Autoantibodies are associated with worse outcomes in MASLD
حسب: Anna Soria, وآخرون
منشور في: (2025-10-01)

Phosphatidylethanol and ethyl glucuronide to categorize alcohol consumption in alcohol-related cirrhosis
حسب: Benedict T.K. Vanlerberghe, وآخرون
منشور في: (2025-08-01)

Editorial: Unraveling the links between nutrients and metabolic dysfunction-associated liver disease: insights and implications
حسب: Bruno Ramos-Molina, وآخرون
منشور في: (2024-11-01)

Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intake
حسب: Emil Deleuran Hansen, وآخرون
منشور في: (2025-01-01)

Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
حسب: Gi-Ae Kim, وآخرون
منشور في: (2023-10-01)

Chronic liver disease is an important risk factor for worse outcomes in acute pancreatitis: a systematic review and meta-analysis
حسب: Jakub Hoferica, وآخرون
منشور في: (2024-07-01)

The Comparative Safety and Efficacy of Resmetirom and Semaglutide in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review
حسب: Jahnavi Udaikumar, وآخرون
منشور في: (2025-06-01)